27.07.2017 • NewsAustraliaAzelisElaine Burridge

Azelis Expands In Australia/New Zealand

The acquisition strengthens Azelis’ presence in the region and positions it...
The acquisition strengthens Azelis’ presence in the region and positions it among the top distributors in the two countries. Australia and New Zealand are wealthy countries, rich in natural resources with growing populations, said Azelis’ CEO, Hans Joachim Müller

Azelis has acquired Chemcolour, a leading supplier of specialty chemicals and food ingredients in Australia and New Zealand, for an undisclosed sum.

The acquisition strengthens Azelis’ presence in the region and positions it among the top distributors in the two countries. Australia and New Zealand are wealthy countries, rich in natural resources with growing populations, said Azelis’ CEO, Hans Joachim Müller, adding that Chemcolour is a great platform to extend agreements with its existing, global principal suppliers.

Chemcolour Australia has a manufacturing plant in Sydney and application and development laboratories in both Sydney and Melbourne. The New Zealand business has its primary manufacturing facility in Auckland with secondary blending facilities in Christchurch. The distributor also performs contract manufacture for several well known companies.

The transaction is expected to complete over the next months. All 90 of Chemcolour’s employees will transfer to Azelis.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.